Mckenna; Kelly Marie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mckenna; Kelly Marie.The latest application filed is for "treatment of cutaneous t cell lymphoma with targeting of cd47 pathway".
- Mckenna; Kelly Marie - Palo Alto CA
| Patent | Date |
|---|---|
| Treatment Of Cutaneous T Cell Lymphoma With Targeting Of Cd47 Pathway App 20220119523 - Weissman; Irving L. ; et al. | 2022-04-21 |
| Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20220033506 - Weissman; Irving L. ; et al. | 2022-02-03 |
| Treatment of cancer with dual targeting of CD47 and EGFR Grant 11,130,813 - Weissman , et al. September 28, 2 | 2021-09-28 |
| Treatment Of Cancer With Combinations Of Immunoregulatory Agents App 20210230276 - Willingham; Stephen ; et al. | 2021-07-29 |
| Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20190322751 - Weissman; Irving L. ; et al. | 2019-10-24 |
| Treatment of cancer with dual targeting of CD47 and EGFR Grant 10,344,094 - Weissman , et al. July 9, 2 | 2019-07-09 |
| Treatment Of Cancer With Combinations Of Immunoregulatory Agents App 20170210803 - Willingham; Stephen ; et al. | 2017-07-27 |
| Treatment Of Cancer With Dual Targeting Of Cd47 And Egfr App 20170166645 - Weissman; Irving L. ; et al. | 2017-06-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 